News
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is among the best NASDAQ stocks under $50 to buy. Analysts at H.C. Wainwright have ...
Prothena Corporation plc (NASDAQ:PRTA) is among the best NASDAQ stocks under $50 to buy. Roche, a partner of Prothena ...
Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...
Roche has announced that it will be advancing its Prothena-partnered investigational Parkinson’s disease (PD) drug ...
20h
Stocktwits on MSNRoche Stock Slides After Failed Blood Cancer Trial With AbbVie, But Parkinson’s Therapy Progress Boosts Retail MoodShares of Roche drew increased retail attention Monday after the Swiss drugmaker said it would move its investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results